Cargando…

Pathophysiological differences between atrial fibrillation subgoups: Is there a fibrillatory-induced atherosclerotic disease progression?

Detalles Bibliográficos
Autor principal:	Goette, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567199/ https://www.ncbi.nlm.nih.gov/pubmed/34761099 http://dx.doi.org/10.1016/j.ijcha.2021.100892

Ejemplares similares

Effect of flecainide on atrial fibrillatory rate in a large animal model with induced atrial fibrillation
por: Hesselkilde, Eva Z., et al.
Publicado: (2017)

Effects of dofetilide and ranolazine on atrial fibrillatory rate in a horse model of acutely induced atrial fibrillation
por: Carstensen, Helena, et al.
Publicado: (2019)

Atrial fibrillatory rate as predictor of recurrence of atrial fibrillation in horses treated medically or with electrical cardioversion
por: Buhl, Rikke, et al.
Publicado: (2022)

Fibrillatory Wave Amplitude Evolution during Persistent Atrial Fibrillation Ablation: Implications for Atrial Substrate and Fibrillation Complexity Assessment
por: Squara, Fabien, et al.
Publicado: (2022)

Fine Fibrillatory Wave as a Risk Factor for Heart Failure Events in Patients With Atrial Fibrillation: The Fushimi Atrial Fibrillation (AF) Registry
por: Kawaji, Tetsuma, et al.
Publicado: (2022)

Effective termination of atrial fibrillation by SK channel inhibition is associated with a sudden organization of fibrillatory conduction
por: Gatta, Giulia, et al.
Publicado: (2021)

Correction to: Fine Fibrillatory Wave as a Risk Factor for Heart Failure Events in Patients With Atrial Fibrillation: The Fushimi Atrial Fibrillation (AF) Registry
Publicado: (2022)

Role of interatrial conduction in atrial fibrillation: Mechanistic insights from renewal theory–based fibrillatory dynamic analysis
por: Quah, Jing Xian, et al.
Publicado: (2022)

Oversensing of atrial fibrillatory waves in a subcutaneous implantable cardioverter-defibrillator
por: Karnik, Ankur A., et al.
Publicado: (2017)

Atrial Cardiomyopathy: Pathophysiology and Clinical Consequences
por: Goette, Andreas, et al.
Publicado: (2021)

Early differentiation of long-standing persistent atrial fibrillation using the characteristics of fibrillatory waves in surface ECG multi-leads
por: Park, Junbeom, et al.
Publicado: (2019)

Surface ECG–based complexity parameters for predicting outcomes of catheter ablation for nonparoxysmal atrial fibrillation: efficacy of fibrillatory wave amplitude
por: Park, Jong-Il, et al.
Publicado: (2022)

Preoperative Prediction of Catheter Ablation Outcome in Persistent Atrial Fibrillation Patients through Spectral Organization Analysis of the Surface Fibrillatory Waves
por: Escribano, Pilar, et al.
Publicado: (2022)

Ventricular fibrillation mechanism and global fibrillatory organization are determined by gap junction coupling and fibrosis pattern
por: Handa, Balvinder S, et al.
Publicado: (2020)

Translational Studies on Anti-Atrial Fibrillatory Action of Oseltamivir by its in vivo and in vitro Electropharmacological Analyses
por: Kambayashi, Ryuichi, et al.
Publicado: (2021)

Stroke, Dementia, and Atrial Fibrillation: From Pathophysiologic Association to Pharmacological Implications
por: Russo, Vincenzo, et al.
Publicado: (2020)

Is Right Atrial Remodeling an Additional Marker for the Progression of Atrial Fibrillation?
por: Park, Jin-Kyu
Publicado: (2023)

Altered Atrial Metabolism: An Underappreciated Contributor to the Initiation and Progression of Atrial Fibrillation
por: Ghezelbash, Shokoufeh, et al.
Publicado: (2015)

Ventricular fibrillatory frequency and its correlation with transthoracic defibrillation current requirement
por: Vostrikov, VA, et al.
Publicado: (2003)

New concepts in atrial fibrillation pathophysiology
por: Hermans, Ben J. M., et al.
Publicado: (2022)

Oxidative Stress and Microcirculatory Flow Abnormalities in the Ventricles during Atrial Fibrillation
por: Goette, Andreas, et al.
Publicado: (2012)

Ten years of non-vitamin K antagonists oral anticoagulants for stroke prevention in atrial fibrillation: is warfarin obsolete?
por: Hammwöhner, Matthias, et al.
Publicado: (2020)

Antioxidant Properties of Oral Antithrombotic Therapies in Atherosclerotic Disease and Atrial Fibrillation
por: Falco, Luigi, et al.
Publicado: (2023)

Anaphylaxis-Induced Atrial Fibrillation and Anesthesia: Pathophysiologic and Therapeutic Considerations
por: Kounis, Nicholas G, et al.
Publicado: (2020)

Atrial fibrillation progression: another step in the RACE to full understanding
por: Capucci, Alessandro, et al.
Publicado: (2023)

Atrial Fibrillation
por: Gassanov, Natig, et al.
Publicado: (2013)

Atrial Fibrillation
por: Erol, Çetin
Publicado: (2022)

Interaction Between Heart Failure and Atrial Fibrillation
por: Kim, Yun Gi
Publicado: (2022)

Pathophysiology of the atherosclerotic rabbit.
por: Lee, R J, et al.
Publicado: (1978)

Role of neural modulation in the pathophysiology of atrial fibrillation
por: Male, Shailesh, et al.
Publicado: (2014)

Calcium in the Pathophysiology of Atrial Fibrillation and Heart Failure
por: Denham, Nathan C., et al.
Publicado: (2018)

Novel insights in pathophysiology of postoperative atrial fibrillation
por: Kharbanda, Rohit K., et al.
Publicado: (2021)

Atrial fibrillation patients undergoing percutaneous coronary intervention: dual or triple antithrombotic therapy with non-vitamin K antagonist oral anticoagulants
por: Goette, Andreas, et al.
Publicado: (2020)

The Association Between Rheumatoid Arthritis and Atrial Fibrillation: Epidemiology, Pathophysiology and Management
por: Qian, Yezhou, et al.
Publicado: (2023)

The correlation between gut microbiome and atrial fibrillation: pathophysiology and therapeutic perspectives
por: Li, Na, et al.
Publicado: (2023)

Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation
por: Aliot, Etienne, et al.
Publicado: (2011)

Atrial fibrillation in the elderly
por: Martínez-Sellés, Manuel, et al.
Publicado: (2017)

Right atrial blood supply and complexity of induced atrial fibrillation: What’s left?()
por: Van Wagoner, David R.
Publicado: (2021)

Atrial High-Rate Episodes, Subclinical Atrial Fibrillation and Short-Duration Clinical Atrial Fibrillation: Different Names for the Same Arrhythmia or a New Player On the Pitch?
por: Benezet-Mazuecos, Juan, et al.
Publicado: (2020)

Integrated care of patients with atrial fibrillation: the 2016 ESC atrial fibrillation guidelines
por: Kirchhof, Paulus
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fipcmogg9u59s7okvkcn68t8dr